COST meeting 2023

COST action CA21113 GenE-Humdi meeting

The principal aim of the GenE-HumDi Action is to bring together pharmaceutical companies, academic institution, science and regulatory agencies, biotechnology firms, patient advocacy association and information technology, in order to tackle knowledge fragmentation with the aim to accelerate the translation of GE technologies to the treatment of human diseases. IN this context, COST organize the first meeting of the Gene Editing for the treatment of Humans Diseases.